Theranexus
ALTHX | PA
Overview
Corporate Details
- ISIN(s):
- FR0013286259
- LEI:
- 969500BFCV6IC7MFQP20
- Country:
- France
- Address:
- 60 AVENUE ROCKEFELLER, 69008 LYON
- Website:
- https://www.theranexus.com/en/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Theranexus is an innovative biopharmaceutical company that emerged from the French Alternative Energies and Atomic Energy Commission (CEA). The company focuses on the research and development of drug candidates for the treatment of rare neurological diseases. It utilizes a unique, proprietary platform for the identification and characterization of advanced therapy drug candidates. Theranexus's lead candidate is in clinical development for Batten disease, addressing a significant unmet medical need.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Theranexus.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-13 18:00 |
Regulatory News Service
THERANEXUS AND BEYOND BATTEN DISEASE FOUNDATION ANNOUNCE STRONG POSITIVE REAL-W…
|
English | 391.8 KB | |
| 2025-05-13 18:00 |
Business and Financial Review
THERANEXUS ET LA FONDATION BEYOND BATTEN DISEASE ANNONCENT DES DONNÉES EN VIE R…
|
French | 352.9 KB | |
| 2025-04-29 19:05 |
Registration Form
URD 2024
|
French | 10.6 MB | |
| 2025-04-29 19:00 |
Earnings Release
THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT A…
|
English | 336.5 KB | |
| 2025-04-29 19:00 |
Earnings Release
THERANEXUS PUBLIE SES RÉSULTATS ANNUELS 2024, FAIT LE POINT SUR SES ACTIVITÉS E…
|
French | 297.3 KB | |
| 2025-03-06 18:00 |
Regulatory News Service
MODIFICATION DU CONTRAT DE LIQUIDITÉ CONFIÉ À PORTZAMPARC
|
French | 272.5 KB | |
| 2025-01-23 18:15 |
Report Publication Announcement
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
|
English | 262.8 KB | |
| 2025-01-23 18:00 |
Report Publication Announcement
THERANEXUS PUBLIE SON AGENDA FINANCIER POUR L'EXERCICE 2025
|
French | 254.5 KB | |
| 2025-01-16 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d'actions c…
|
French | 168.8 KB | |
| 2025-01-09 18:00 |
Report Publication Announcement
THERANEXUS ANNOUNCES THE PUBLICATION OF ITS LETTER TO SHAREHOLDERS
|
English | 179.9 KB | |
| 2025-01-09 18:00 |
Report Publication Announcement
THERANEXUS ANNONCE LA PUBLICATION DE SA LETTRE AUX ACTIONNAIRES
|
French | 181.7 KB | |
| 2024-12-17 18:15 |
Capital/Financing Update
THERANEXUS PRESENTS AN UPDATE OF ITS CASH POSITION AND FINANCING HORIZON
|
English | 212.3 KB | |
| 2024-12-17 18:15 |
Capital/Financing Update
THERANEXUS FAIT UN POINT SUR SA POSITION DE TRÉSORERIE ET SON HORIZON DE FINANC…
|
French | 230.9 KB | |
| 2024-12-17 18:00 |
M&A Activity
THERANEXUS ET EXELTIS (INSUD PHARMA) ANNONCENT UN ACCORD DE LICENCE POUR LA COM…
|
French | 178.0 KB | |
| 2024-12-17 18:00 |
M&A Activity
THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIA…
|
English | 177.4 KB |
Automate Your Workflow. Get a real-time feed of all Theranexus filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Theranexus via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
